A 73-year-old woman with non-valvular atrial fibrillation, hypertension, and a prior lacunar stroke presents for routine review. Her CHA2DS2-VASc score is 5. She has normal renal function and no history of major bleeding. According to Canadian atrial fibrillation and stroke prevention recommendations, what is the most appropriate long-term antithrombotic strategy?